Total artificial heart developer Scandinavian Real Heart has, subject to approval from the AGM on June 14, decided to carry out a rights issue of up to 34,979,248 units. The rights issue, if fully subscribed, will raise approximately SEK56m (US$5.4m) before transaction costs. The issue is covered to approximately 60.6% through subscription commitments and underwriting…
Home Healthcare Markets International Business Sweden: Realheart plans rights issue to fund further preclinical studies